AI/ML Alliances May Give Larger Firms Another Edge, S&P Warns

All big pharmas have proprietary artificial intelligence or machine learning platform or are partnering with third parties, according to a survey by S&P Global. Their deep pockets and early adoption are locking in a competitive advantage.